Otmar Wiestler appointed to Bayer supervisory board

Germany-based Bayer has appointed Otmar Wiestler to its supervisory board with immediate effect.

Since January 2004 Wiestler has been chairman of Bayer's management board and scientific director of the German cancer research centre in Heidelberg, Germany. He has also been chairman of the advisory committee and a member of the board of German Cancer Aid.

In addition to these roles, he served in the executive committee of the Helmholtz Association from 2007 to 2012.

Wiestler succeeds Klaus Kleinfeld, who left the position in September in order to concentrate on other office and honorary posts, some of which are located in the US.

In regards to the appointment, Werner Wenning, chairman of Bayer's supervisory board, said: “We would like to thank Mr Kleinfeld for our very successful and trusting cooperation. In Prof Wiestler we have found a competent successor with extensive scientific expertise.”